mTOR in radiotherapy of lung cancer: Mechanisms of radiation resistance and therapeutic implications (Review) [0.03%]
肺癌放射治疗中的mTOR：放射抵抗机制及其治疗意义（综述）
Xiao Pang,Huai Liu,Ying Long et al.
Xiao Pang et al.
Radiotherapy is an important treatment for tumors; however, some patients exhibit poor sensitivity to radiation, leading to unsatisfactory outcomes. mTOR regulates critical processes such as cell proliferation, autophagy and DNA repair, ser...
[Retracted] Characterization of side population cells isolated from the colon cancer cell line SW480 [0.03%]
[撤回]从结肠癌细胞系SW480中分离的侧群细胞的特征化
Binghong Xiong,Li Ma,Xiang Hu et al.
Binghong Xiong et al.
Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that certain of the tumor images shown in Fig. 4A on p. 1180 were unexpectedly similar, albeit the images appeared to have been horiz...
Cancer stem cell heterogeneity‑inspired therapeutics for enhancing tumor treatment outcomes (Review) [0.03%]
癌症干细胞异质性启发的疗法可增强肿瘤治疗效果（综述）
Hanning Xu,Qunchao Si,Yongyao Song et al.
Hanning Xu et al.
Cancer stem cells (CSCs), a small subpopulation of cancer cells that exhibit stem‑like properties, possess the ability to differentiate and self‑renew. These capabilities enable CSCs to act as tumor‑initiating cells, driving tumorigenesi...
[Expression of Concern] MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion [0.03%]
[表达担忧]MUC1是STAT3的下游靶点并调节肺癌细胞存活和侵袭
Jingchun Gao,Matthew J Mcconnell,Bin Yu et al.
Jingchun Gao et al.
Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that the Bcl‑2 protein bands shown for the HCC827 cell line in the western blots in Fig. 3A on p. 342 were unexpectedly similar to t...
[Retracted] GDC‑0152 attenuates the malignant progression of osteosarcoma promoted by ANGPTL2 via PI3K/AKT but not p38MAPK signaling pathway [0.03%]
[GDC-0152通过PI3K/AKT而非p38MAPK信号通路抑制ANGPTL2促进的骨肉瘤恶性进展]（已撤稿）
Lin Yang,Taipengfei Shu,Yingjian Liang et al.
Lin Yang et al.
Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that, for the MTT assay experiments shown in Fig. 2A on p. 1655, the GDC‑0152/ANGPTL2 panel appeared to overlap with the ANGPTL2 pan...
Regulation and reversal of paclitaxel resistance via the STAT1‑mediated apoptotic pathway in ovarian cancer [0.03%]
调控STAT1介导的卵巢癌耐药逆转凋亡通路
Fanchen Wang,Xiaolin Xu,Bin Guan et al.
Fanchen Wang et al.
Ovarian cancer (OC) is the most lethal disease in women. Resistance to paclitaxel (PTX) is the main cause of treatment failure in patients with OC. The STAT1 protein is a transcription factor implicated in a variety of cellular processes. T...
[Retracted] Cdc42 expression in cervical cancer and its effects on cervical tumor invasion and migration [0.03%]
宫颈癌中Cdc42的表达及其对宫颈肿瘤侵袭和迁移的影响
Hongnan Ye,Youyi Zhang,Li Geng et al.
Hongnan Ye et al.
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that, for the transfection experiments shown in Fig. 3 on p. 760, two pairs of data panels showed a surprisingly high level of similarity,...
Emerging biomarkers in prostate cancer diagnosis and treatment: Insights into genetic, RNA and metabolic markers (Review) [0.03%]
前列腺癌诊断和治疗中新兴的生物标志物：遗传、RNA和代谢标志物的见解（综述）
Yuanshe Huang,Jingxin Mao,Xiaobing Li
Yuanshe Huang
Prostate cancer remains one of the most prevalent malignancies and a major cause of cancer‑related mortality among men worldwide. Despite widespread use of prostate‑specific antigen testing, current diagnostic approaches suffer from low s...
Roles of interleukins in spasmolytic polypeptide‑expressing metaplasia (Review) [0.03%]
肠黏蛋白表达上皮代谢的异位增生中各种白细胞介素的作用（文献综述）
Jiale Ma,Tiancheng Zhan,Xinyuan Zhang et al.
Jiale Ma et al.
Gastric cancer (GC) is a major global health burden, ranking fifth in incidence and third in cancer‑related mortality. By 2040, there are expected to be ~1.8 million new cases and 1.3 million fatalities associated with GC. Spasmolytic poly...
The tumor microenvironment in lung cancer: Heterogeneity, therapeutic resistance and emerging treatment strategies (Review) [0.03%]
肺癌肿瘤微环境：异质性、治疗抵抗和新兴疗法（综述）
Li Liu,Li Yang,Hongmin Li et al.
Li Liu et al.
Lung cancer remains a leading cause of cancer‑related death. Despite advances in targeted therapies and immunotherapy, treatment outcomes remain suboptimal due to tumor heterogeneity and therapeutic resistance. The tumor microenvironment (...